Blog
RSS FeedPosted by Michael Wonder on 23 Mar 2018
Health Canada approves Rituxan subcutaneous formulation for Canadians with chronic lymphocytic leukaemia
22 March 2018 - Rituxan SC is a new treatment option for Canadians living with one of the most common forms ...
Posted by Michael Wonder on 16 Mar 2018
Ipsen announces Health Canada approval of Dysport Therapeutic (abobotulinumtoxinA) for the treatment of lower limb spasticity in adults
15 March 2018 - With this approval, Dysport Therapeutic now has the broadest label of all approved botulinum neurotoxins for spasticity, ...
Posted by Michael Wonder on 14 Mar 2018
Valeant receives Health Canada approval of Siliq (brodalumab) for moderate-to-severe plaque psoriasis
14 March 2018 - Valeant Canada announced that Health Canada granted on 6 March the Notice of Compliance for Siliq (brodalumab) ...
Posted by Michael Wonder on 27 Feb 2018
Health Canada has approved Fasenra (benralizumab injection) for patients with severe eosinophilic asthma
26 February 2018 - AstraZeneca Canada today announced that Health Canada has approved Fasenra (benralizumab injection) as an add-on maintenance treatment ...
Posted by Michael Wonder on 23 Feb 2018
Health Canada approves Bavencio (avelumab for injection) for the treatment of metastatic Merkel cell carcinoma in previously treated adult patients
22 February 2018 - First Health Canada approved treatment for rare and aggressive type of skin cancer. ...
Posted by Michael Wonder on 16 Feb 2018
Health Canada approves new indication for Zytiga (abiraterone acetate), broadening its use for treatment of newly diagnosed metastatic prostate cancer
15 February 2018 - Zytiga, used in combination with prednisone and androgen deprivation therapy, was shown to reduce the risk ...
Posted by Michael Wonder on 16 Feb 2018
Health Canada approves Ocrevus (ocrelizumab) for Canadians living with primary progressive multiple sclerosis
15 February 2018 - Ocrevus is a new treatment for a rare and worsening form of MS that impacts 10-15% ...
Posted by Michael Wonder on 14 Feb 2018
Health Canada approves Ipsen's Somatuline Autogel for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours
13 February 2018 - Somatuline Autogel is the first and only somatostatin analog approved in Canada to treat enteropancreatic neuroendocrine ...
Posted by Michael Wonder on 04 Feb 2018
Tagrisso (osimertinib) receives full Health Canada approval for targeted treatment of non-small-cell lung cancer
31 January 2018 - Approval based on Phase III AURA3 trial that demonstrated significant improvement in progression-free survival with Tagrisso compared ...
Posted by Michael Wonder on 02 Feb 2018
New treatment option for adults with ADHD: Foquest (methylphenidate controlled release capsules) now available in Canada
1 February 2018 - First and only methylphenidate product approved in Canada with a 16-hour duration of action. ...
Posted by Michael Wonder on 24 Jan 2018
Lartruvo (olaratumab) approved in Canada for the treatment of advanced soft tissue sarcoma in adults
24 January 2018 - Health Canada has issued a Notice of Compliance with Conditions for Lartruvo (olaratumab). ...
Posted by Michael Wonder on 10 Jan 2018
Ozempic approved in Canada for the treatment of adults with type 2 diabetes
9 January 2018 - Ozempic demonstrated clinically meaningful improvements in blood sugar and body weight vs comparators. ...
Posted by Michael Wonder on 10 Jan 2018
Ipsen Biopharmaceuticals Canada announces Health Canada approval of Dysport Therapeutic (abobotulinumtoxinA) for the treatment of lower limb spasticity in children aged two and older
9 January 2018 - Ipsen Biopharmaceuticals Canada today announced that Health Canada has approved Dysport Therapeutic (abobotulinumtoxinA) for the treatment ...
Posted by Michael Wonder on 04 Jan 2018
Xiidra (lifitegrast ophthalmic solution 5%) approved by Health Canada to treat the signs and symptoms of dry eye disease
3 January 2018 - Canada approval represents Shire’s first international market authorisation for Xiidra outside of the United States. ...
Posted by Michael Wonder on 13 Dec 2017
New concentrated insulin approved and available for Canadian patients
12 December 2017 - Entuzity KwikPen is five times more concentrated than the current option. ...